This form will provide you with guidance as to whether your patient is (or you are) eligible for government-approved COVID-19 treatments such as monoclonal antibody therapy (intravenous) or nirmatrelvir/ritonavir (Paxlovid - oral pills). It is based on the Ontario Covid-19 Drugs and Biologics Clinical Practice Guidelines Working Group: Therapeutic Management of Adult Patients with Covid-19 - updated Feb 23, 2022:  https://doi.org/10.47326/ocsat.cpg.2022.10.0 
Please note: This may not be comprehensive and may not be applicable to every patient's situation - Health care professionals should use their own clinical judgement, and patients should reach out to a health care professional with any questions. Based on the document, there are priority populations that should be considered for access to Covid-19 drugs and therapeutics.   (Google form developed by Dr. Sohal Goyal)